An experimental drug being tested on people with Alzheimer’s disease is showing promise and is very encouraging, according to Tim Harrington, a spokesman for the Iowa chapter of the Alzheimer’s Association. The drug is called Lecanemab and medical reports out this week say it can slow the rate of cognitive decline by 27%, which Harrington […]